Sergio L. Santillana
2018
In 2018, Sergio L. Santillana earned a total compensation of $924.6K as Former Chief Medical Officer at Merrimack Pharmaceuticals, a 42% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $143,327 |
|---|---|
| Option Awards | $390,830 |
| Salary | $379,171 |
| Other | $11,263 |
| Total | $924,591 |
Santillana received $390.8K in option awards, accounting for 42% of the total pay in 2018.
Santillana also received $143.3K in non-equity incentive plan, $379.2K in salary and $11.3K in other compensation.
Rankings
In 2018, Sergio L. Santillana's compensation ranked 9,570th out of 14,244 executives tracked by ExecPay. In other words, Santillana earned more than 32.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,570 out of 14,244 | 33rd |
Division Manufacturing | 3,847 out of 5,765 | 33rd |
Major group Chemicals And Allied Products | 1,449 out of 2,128 | 32nd |
Industry group Drugs | 1,220 out of 1,817 | 33rd |
Industry Pharmaceutical Preparations | 940 out of 1,391 | 32nd |
Source: SEC filing on September 26, 2019.
Santillana's colleagues
We found two more compensation records of executives who worked with Sergio L. Santillana at Merrimack Pharmaceuticals in 2018.